Market-price fluctuations in investment securities
First written in FY2018. 8 of 19 entries say "Materialised", first in FY2019-Q2. Latest entry: FY2025.
Tpr moved to the "Worse" side of this theme in 2018, 1 year before the typical company in this theme (2019).
The whole theme swung hardest in 2019: 69 of 144 companies on the "Worse" side.
53 other companies' latest entry also says "Mitigated".
- FY2025MitigatedAnnual report
「During the current consolidated fiscal year, the Company recognized ¥0 million in impairment losses on investment securities.」
Impairment losses on investment securities decreased from ¥131 million in the previous fiscal year to ¥0 million in the current fiscal year. - FY2025-H1MitigatedAnnual report
「Impairment loss on investment securities 133 —」
No impairment losses on investment securities were recognized in the current interim consolidated accounting period, compared with ¥133 million in the cumulative period of the previous fiscal year. - FY2024-Q3RestatedAnnual report
「Impairment loss on investment securities 920 140」
Impairment losses on investment securities decreased from ¥920 million in the cumulative period of the previous fiscal year to ¥140 million in the cumulative third quarter of the current fiscal year, representing a year-on-year decrease. - FY2024-Q2MitigatedAnnual report
「Impairment loss on investment securities 760 133」
Impairment losses on investment securities decreased from ¥760 million in the cumulative period of the previous fiscal year to ¥133 million in the cumulative second quarter of the current fiscal year. - FY2024-Q1Valuation loss on investment securities decreased year on yearAnnual report
「Impairment loss on investment securities 494 102」
The impairment loss on investment securities decreased from ¥494 million in the cumulative period of the same quarter of the previous year to ¥102 million during the three months ended the first quarter. - FY2023WorsenedAnnual report
「During the consolidated fiscal year, the company recognised an impairment loss of ¥929 million on investment securities.」
The risk of fluctuations in the market prices of investment securities materialised as an impairment loss of ¥929 million, compared with ¥200 million in the previous year. - FY2023-Q3WorsenedAnnual report
「Impairment loss on investment securities 200 920」
The impairment loss on investment securities increased from ¥200 million in the cumulative period of the same quarter of the previous year to ¥920 million during the nine months ended the third quarter. - FY2023-Q2WorsenedAnnual report
「Impairment loss on investment securities 200 760」
The impairment loss on investment securities increased from ¥200 million in the cumulative period of the same quarter of the previous year to ¥760 million during the six months ended the second quarter. - FY2023-Q1WorsenedAnnual report
「Impairment loss on investment securities 200 494」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥494 million was recognised during the three months ended the first quarter, up from ¥200 million in the cumulative period of the same quarter of the previous year. - FY2022-Q3RestatedAnnual report
「Impairment loss on investment securities 89 200」
An impairment loss of ¥200 million on investment securities was recognised during the nine months ended the third quarter. - FY2022-Q1MaterialisedAnnual report
「Impairment loss on investment securities 200」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥200 million was actually recognised during the three months ended the first quarter. - FY2021-Q3MaterialisedAnnual report
「Impairment loss on investment securities 18 89」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥89 million was recognised during the nine months ended the third quarter. - FY2020MaterialisedAnnual report
「During the consolidated fiscal year, the company recognised an impairment loss of ¥23 million on investment securities.」
The risk of fluctuations in the market prices of investment securities continued to materialise as an impairment loss of ¥23 million during the fiscal year. - FY2020-Q2MaterialisedAnnual report
「Impairment loss on investment securities 172 18」
An impairment loss of ¥18 million on investment securities was recognised during the six months ended the second quarter. - FY2020-Q1MaterialisedAnnual report
「Impairment loss on investment securities ¥17 million」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥17 million was actually recognised during the three months ended the first quarter. - FY2019MaterialisedAnnual report
「During the consolidated fiscal year, the company recognised an impairment loss of ¥381 million on investment securities.」
The risk of fluctuations in the market prices of investment securities materialised as an impairment loss of ¥381 million for the full fiscal year. - FY2019-Q3MaterialisedAnnual report
「Impairment loss on investment securities 238」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥238 million was recognised during the nine months ended the third quarter. - FY2019-Q2MaterialisedAnnual report
「Impairment loss on investment securities 172」
Regarding the risk of fluctuations in the market prices of investment securities, an impairment loss of ¥172 million was actually recognised during the six months ended the second quarter. quantified is true, materialized is true. - FY2018First statedAnnual report
「The Group holds marketable investment securities. Fluctuations in share prices may result in valuation losses on these holdings and affect the Group's results and financial position.」
Explicitly identifies the possibility of valuation losses from fluctuations in market prices of marketable shares as an investment risk.